An Act amending the act of November 3, 2022 (P.L.2135, No.150), known as the Childhood Blood Lead Test Act, further providing for title of act, for legislative purpose, for definitions, for lead poisoning prevention, assessment and testing and for duties of department.

HB 1270 amends Pennsylvania's Childhood Blood Lead Test Act to require health care practitioners to offer blood lead testing for children before they turn nine months old, replacing the previous 24-month deadline. If a child hasn't been tested by nine months, practitioners must offer testing by age two, and by age six if still untested. The bill also mandates that practitioners assess lead exposure risks and obtain written parental consent before testing. This change directly affects children under 18, their parents, and health care providers in Pennsylvania who treat young children.